Neoadjuvant chemo-immunotherapy following concurrent immuno-chemoradiotherapy and immune-maintenance therapy as primary treatment for locally advanced cervical cancer: A prospective, single-arm, phase 2 trial.

Fo-Ping Chen, Weijun Ye, Xiaodan Huang et al.|Journal of Clinical Oncology|2024

Cited by 1